Inventor
BAICHWAL ANAND R
US39 patents
⚠️ This page may combine multiple inventors who share the name “BAICHWAL ANAND R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MENDELL CO INC EDWARD
19 patentsUS6093420AJul 25, 2000
Sustained release matrix for high-dose insoluble drugs
MENDELL CO INC EDWARD126 citations99
US5472711ADec 5, 1995
Agglomerated hydrophilic complexes with multi-phasic release characteristics
MENDELL CO INC EDWARD122 citations99
US5455046AOct 3, 1995
Sustained release heterodisperse hydrogel systems for insoluble drugs
MENDELL CO INC EDWARD127 citations99
US5128143AJul 7, 1992
Sustained release excipient and tablet formulation
MENDELL CO INC EDWARD146 citations99
US4994276AFeb 19, 1991
Directly compressible sustained release excipient
MENDELL CO INC EDWARD158 citations99
US6056977AMay 2, 2000
Once-a-day controlled release sulfonylurea formulation
MENDELL CO INC EDWARD117 citations98
US5399359AMar 21, 1995
Controlled release oxybutynin formulations
MENDELL CO INC EDWARD121 citations98
US5330761AJul 19, 1994
Bioadhesive tablet for non-systemic use products
MENDELL CO INC EDWARD124 citations98
US5512297AApr 30, 1996
Sustained release heterodisperse hydrogel systems for insoluble drugs
MENDELL CO INC EDWARD91 citations97
US6136343AOct 24, 2000
Sustained release heterodisperse hydrogel systems for insoluble drugs
MENDELL CO INC EDWARD29 citations96
US6039980AMar 21, 2000
Sustained release excipient
MENDELL CO INC EDWARD69 citations96
US5846563ADec 8, 1998
Sustained release heterodisperse hydrogel systems for insoluble drugs
MENDELL CO INC EDWARD39 citations96
US5670168ASep 23, 1997
Agglomerated hydrophilic complexes with multi-phasic release characteristics
MENDELL CO INC EDWARD62 citations96
US5667801ASep 16, 1997
Sustained release heterodisperse hydrogel systems for insoluble drugs
MENDELL CO INC EDWARD36 citations96
US5478574ADec 26, 1995
Agglomerated hydrophilic complexes with multi-phasic release characteristics
MENDELL CO INC EDWARD47 citations96
US5399358AMar 21, 1995
Sustained release formulations for 24 hour release of metroprolol
MENDELL CO INC EDWARD76 citations96
US5169639ADec 8, 1992
Controlled release verapamil tablets
MENDELL CO INC EDWARD53 citations96
US5135757AAug 4, 1992
Compressible sustained release solid dosage forms
MENDELL CO INC EDWARD116 citations96
US6245355B1Jun 12, 2001
Sustained release matrix for high-dose insoluble drugs
MENDELL CO INC EDWARD16 citations93
BAICHWAL ANAND R
6 patentsUS8389008B2Mar 5, 2013
Delayed release dosage forms
BAICHWAL ANAND R32 citations87
US8394812B2Mar 12, 2013
Sustained release formulations of nalbuphine
BAICHWAL ANAND R9 citations81
US8771732B2Jul 8, 2014
Sustained release formulations of nalbuphine
BAICHWAL ANAND R3 citations60
US7887841B2Feb 15, 2011
Chronotherapeutic dosage forms and methods of treatment using chronotherapy
BAICHWAL ANAND R1 citations44
US9278076B2Mar 8, 2016
Chronotherapeutic dosage forms
BAICHWAL ANAND R0 citations33
US8679535B2Mar 25, 2014
Sustained release matrix systems for highly soluble drugs
BAICHWAL ANAND R0 citations33
PENWEST PHARMACEUTICALS CO
5 patentsUS6537578B1Mar 25, 2003
Once-a-day controlled release sulfonylurea formulation
PENWEST PHARMACEUTICALS CO16 citations91
US6726930B1Apr 27, 2004
Sustained release heterodisperse hydrogel systems for insoluble drugs
PENWEST PHARMACEUTICALS CO7 citations74
US6689386B2Feb 10, 2004
Sustained release matrix for high-dose insoluble drugs
PENWEST PHARMACEUTICALS CO6 citations74
US6875793B2Apr 5, 2005
Once-a-day controlled release sulfonylurea formulation
PENWEST PHARMACEUTICALS CO2 citations61
US8765175B2Jul 1, 2014
Sustained release formulation of nalbuphine
PENWEST PHARMACEUTICALS CO1 citations60
ENDO PHARMACEUTICALS INC
4 patentsUS9351938B2May 31, 2016
Sustained release formulation of nalbuphine
ENDO PHARMACEUTICALS INC1 citations60
US9186330B2Nov 17, 2015
Sustained release formulation of nalbuphine
ENDO PHARMACEUTICALS INC1 citations50
US10406106B2Sep 10, 2019
Sustained release formulations of nalbuphine
ENDO PHARMACEUTICALS INC0 citations48
US10172798B2Jan 8, 2019
Sustained release formulation of nalbuphine
ENDO PHARMACEUTICALS INC0 citations48